Up a level |
Number of items: 1.
Boyle, Luke D and Wilding, John PH ORCID: 0000-0003-2839-8404
(2014)
A safety evaluation of canagliflozin: a first-in-class treatment for type 2 diabetes.
EXPERT OPINION ON DRUG SAFETY, 13 (11).
pp. 1535-1544.